Literature DB >> 22156527

Role of β-catenin and TCF/LEF family members in transcriptional activity of HIV in astrocytes.

Srinivas D Narasipura1, Lisa J Henderson, Sidney W Fu, Liang Chen, Fatah Kashanchi, Lena Al-Harthi.   

Abstract

The Wnt/β-catenin pathway is involved in diverse cell functions governing development and disease. β-Catenin, a central mediator of this pathway, binds to members of the TCF/LEF family of transcription factors to modulate hundreds of genes. Active Wnt/β-catenin/TCF-4 signaling plays a significant role in repression of HIV-1 replication in multiple cell targets, including astrocytes. To determine the mechanism by which active β-catenin/TCF-4 leads to inhibition of HIV replication, we knocked down β-catenin or TCF/LEF members in primary astrocytes and astrocytomas transiently transfected with an HIV long terminal repeat (LTR)-luciferase reporter that contained an integrated copy of the HIV LTR-luciferase construct. Knockdown of either β-catenin or TCF-4 induced LTR activity by 2- to 3-fold under both the episomal and integrated conditions. This knockdown also increased presence of serine 2-phosphorylated RNA polymerase II (Pol II) on the HIV LTR as well as enhanced its processivity. Knockdown of β-catenin/TCF-4 also impacted tethering of other transcription factors on the HIV promoter. Specifically, knockdown of TCF-4 enhanced binding of C/EBPβ, C/EBPδ, and NF-κB to the HIV LTR, while β-catenin knockdown increased binding of C/EBPβ and C/EBPδ but had no effect on NF-κB. Approximately 150 genes in astrocytes were impacted by β-catenin knockdown, including genes involved in inflammation/immunity, uptake/transport, vesicular transport/exocytosis, apoptosis/cellular stress, and cytoskeleton/trafficking. These findings indicate that modulation of the β-catenin/TCF-4 axis impacts the basal level of HIV transcription in astrocytes, which may drive low level/persistent HIV in astrocytes that can contribute to ongoing neuroinflammation, and this axis also has profound effects on astrocyte biology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22156527      PMCID: PMC3302377          DOI: 10.1128/JVI.06266-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Expression of inflammatory cytokines and inducible nitric oxide synthase in brains of SIV-infected rhesus monkeys: applications to HIV-induced central nervous system disease.

Authors:  T E Lane; M J Buchmeier; D D Watry; H S Fox
Journal:  Mol Med       Date:  1996-01       Impact factor: 6.354

Review 2.  The role of C/EBP isoforms in the control of inflammatory and native immunity functions.

Authors:  V Poli
Journal:  J Biol Chem       Date:  1998-11-06       Impact factor: 5.157

3.  Regulation of HIV-1 long terminal repeats by interaction of C/EBP(NF-IL6) and NF-kappaB/Rel transcription factors.

Authors:  M R Ruocco; X Chen; C Ambrosino; E Dragonetti; W Liu; M Mallardo; G De Falco; C Palmieri; G Franzoso; I Quinto; S Venuta; G Scala
Journal:  J Biol Chem       Date:  1996-09-13       Impact factor: 5.157

4.  The DNA-dependent protein kinase participates in the activation of NF kappa B following DNA damage.

Authors:  S Basu; K R Rosenzweig; M Youmell; B D Price
Journal:  Biochem Biophys Res Commun       Date:  1998-06-09       Impact factor: 3.575

Review 5.  In vivo and in vitro infection of the astrocyte by HIV-1.

Authors:  K Conant; C Tornatore; W Atwood; K Meyers; R Traub; E O Major
Journal:  Adv Neuroimmunol       Date:  1994

6.  In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-alpha RNA in the central nervous system.

Authors:  G J Nuovo; F Gallery; P MacConnell; A Braun
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

7.  HIV-1 infection of subcortical astrocytes in the pediatric central nervous system.

Authors:  C Tornatore; R Chandra; J R Berger; E O Major
Journal:  Neurology       Date:  1994-03       Impact factor: 9.910

8.  Differential expression of three C/EBP isoforms in multiple tissues during the acute phase response.

Authors:  T Alam; M R An; J Papaconstantinou
Journal:  J Biol Chem       Date:  1992-03-15       Impact factor: 5.157

9.  TAR-independent replication of human immunodeficiency virus type 1 in glial cells.

Authors:  O Bagasra; K Khalili; T Seshamma; J P Taylor; R J Pomerantz
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

10.  Activation of the HIV-1 enhancer by the LEF-1 HMG protein on nucleosome-assembled DNA in vitro.

Authors:  P L Sheridan; C T Sheline; K Cannon; M L Voz; M J Pazin; J T Kadonaga; K A Jones
Journal:  Genes Dev       Date:  1995-09-01       Impact factor: 11.361

View more
  60 in total

1.  Human astrocytic cells support persistent coxsackievirus B3 infection.

Authors:  Xiaowei Zhang; Zhenhua Zheng; Bo Shu; Xijuan Liu; Zhenfeng Zhang; Yan Liu; Bingke Bai; Qinxue Hu; Panyong Mao; Hanzhong Wang
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

2.  Epigenetic regulation of HIV-1 latency in astrocytes.

Authors:  Srinivas D Narasipura; Stephanie Kim; Lena Al-Harthi
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

3.  17β-Estradiol inhibits HIV-1 by inducing a complex formation between β-catenin and estrogen receptor α on the HIV promoter to suppress HIV transcription.

Authors:  Erika L Szotek; Srinivas D Narasipura; Lena Al-Harthi
Journal:  Virology       Date:  2013-06-12       Impact factor: 3.616

Review 4.  HIV-1 transcription and latency: an update.

Authors:  Carine Van Lint; Sophie Bouchat; Alessandro Marcello
Journal:  Retrovirology       Date:  2013-06-26       Impact factor: 4.602

5.  TCF1 and LEF1 act as T-cell intrinsic HTLV-1 antagonists by targeting Tax.

Authors:  Guangyong Ma; Jun-ichirou Yasunaga; Hirofumi Akari; Masao Matsuoka
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

6.  Enigma of HIV-1 latent infection in astrocytes: an in-vitro study using protein kinase C agonist as a latency reversing agent.

Authors:  Ashok Chauhan
Journal:  Microbes Infect       Date:  2015-06-02       Impact factor: 2.700

Review 7.  Understanding HIV compartments and reservoirs.

Authors:  Valentina Svicher; Francesca Ceccherini-Silberstein; Andrea Antinori; Stefano Aquaro; Carlo Federico Perno
Journal:  Curr HIV/AIDS Rep       Date:  2014-06       Impact factor: 5.071

8.  Canonical Wnts Mediate CD8+ T Cell Noncytolytic Anti-HIV-1 Activity and Correlate with HIV-1 Clinical Status.

Authors:  Jennillee Wallace; Srinivas D Narasipura; Beverly E Sha; Audrey L French; Lena Al-Harthi
Journal:  J Immunol       Date:  2020-09-04       Impact factor: 5.422

Review 9.  Interplay between Wnt/β-catenin signaling and HIV: virologic and biologic consequences in the CNS.

Authors:  Lena Al-Harthi
Journal:  J Neuroimmune Pharmacol       Date:  2012-10-13       Impact factor: 4.147

10.  Human immunodeficiency virus type 1 (HIV-1) transactivator of transcription through its intact core and cysteine-rich domains inhibits Wnt/β-catenin signaling in astrocytes: relevance to HIV neuropathogenesis.

Authors:  Lisa J Henderson; Amit Sharma; Maria Chiara G Monaco; Eugene O Major; Lena Al-Harthi
Journal:  J Neurosci       Date:  2012-11-14       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.